Haematology

Prof. Dr. Meliha Nalçacı

Doctor and researcher Acıbadem Bakırköy Hastanesi İstanbul
Thrombocythemia, EssentialMyeloproliferative DisordersThrombosisMyelodysplastic SyndromesLeukemia, Myelogenous, Chronic, BCR-ABL PositivePolycythemia VeraMultiple MyelomaAntiphospholipid SyndromeThrombocytopeniaPurpura, Thrombocytopenic, IdiopathicAnemia, AplasticGraft vs Host DiseaseMastocytosisSplenomegalyAnemiaLeukemia, Lymphocytic, Chronic, B-CellLymphoma, Large B-Cell, DiffuseHodgkin DiseaseLeukemia, Myeloid, AcuteBudd-Chiari SyndromeRed-Cell Aplasia, PureHypopituitarism
Open institution page
Suggest a correction

Is this your profile? Claim it and verify your details.

Claim profile

The CV on this page was translated automatically from its original language. See the original

Person ↔ Disease

Which diseases does this doctor work on?

From source
  • Thrombocythemia, Essential 6 publications
    Source: OpenAlex / PubMed MeSHView publications
  • Myeloproliferative Disorders 6 publications
  • Thrombosis 5 publications
  • Myelodysplastic Syndromes 5 publications
  • Leukemia, Myelogenous, Chronic, BCR-ABL Positive 4 publications
  • Polycythemia Vera 4 publications
  • Multiple Myeloma 4 publications
  • Antiphospholipid Syndrome 4 publications
  • Thrombocytopenia 3 publications
  • Purpura, Thrombocytopenic, Idiopathic 3 publications
  • Anemia, Aplastic 3 publications
  • Graft vs Host Disease 2 publications
  • Mastocytosis 2 publications
  • Splenomegaly 2 publications
  • Anemia 2 publications
  • Leukemia, Lymphocytic, Chronic, B-Cell 2 publications
  • Lymphoma, Large B-Cell, Diffuse 2 publications
  • Hodgkin Disease 2 publications
  • Leukemia, Myeloid, Acute 2 publications
  • Budd-Chiari Syndrome 2 publications
  • Red-Cell Aplasia, Pure 2 publications
  • Hypopituitarism 2 publications

CV

Education and experience

From source

Experience

  • 2025Acıbadem Healthcare Groupacibadem.com.tr

Education

  • 1999İstanbul University İstanbul Faculty of Medicine (Professorship)acibadem.com.tr
  • 1999İstanbul University İstanbul Faculty of Medicine, Department of Internal Medical Sciences, Department of Internal Medicine (Associate Professorship)acibadem.com.tr
  • 1994İstanbul University İstanbul Faculty of Medicine, Haematology (subspecialty)acibadem.com.tr
  • 1993İstanbul University İstanbul Faculty of Medicine, Department of Internal Medical Sciences, Department of Internal Medicine (Resident)acibadem.com.tr
  • 1984İstanbul University İstanbul Faculty of Medicine, Internal Medicine (specialty training)acibadem.com.tr
  • 1980İstanbul University İstanbul Faculty of Medicine (medical degree)acibadem.com.tr

Trust

Where does this information come from?

The source is stated next to each piece of information. If you see something wrong, you can suggest a correction.

  • SpecialtyHaematologyacibadem.com.trFrom source
  • InstitutionAcıbadem Bakırköy Hastanesiacibadem.com.trFrom source
  • Area of workThrombocythemia, EssentialExtracted from 6 publications · Model version —From source
  • Publications176 publicationsOpenAlexFrom source
  • Last synchronised4 November 2026 21:10https://www.acibadem.com.tr/doktor/meliha-nalcaci/acibadem.com.tr

Scientific work

Publications on Thrombocythemia, Essential

176 publications

  1. Real-world effectiveness and safety of ruxolitinib in myelofibrosis: a multicenter cohort study (CHART-MF)

    Blood Global Hematology, 2026

    DOI 10.1016/j.bglo.2026.100162 1 citation (OpenAlex) Open-access full textSource: OpenAlex

  2. Comparison of Total Leukocyte Chimerism and Lymphocyte Subset Chimerism for Early Detection of Post-Transplant Complications

    Transplant Immunology, 2026

    DOI 10.1016/j.trim.2026.102361 PMID 41672353 Source: OpenAlex

  3. Analysis of CALR-mutated essential thrombocythemia as a distinct disease entity compared with JAK2 V617F-mutated and triple-negative patients

    TURKISH JOURNAL OF MEDICAL SCIENCES, 2026

    DOI 10.55730/1300-0144.6184 PMID 42058976 Open-access full textSource: OpenAlex

  4. Cytogenetic Diversity of Variant Philadelphia Translocations in Chronic Myeloid Leukemia

    International Journal of Laboratory Hematology, 2026

    DOI 10.1111/ijlh.70146 PMID 42153575 Open-access full textSource: OpenAlex

  5. IDH1 Mutations in Acute Myeloid Leukemia: Frequency and Clinical Features in the Context of FLT3 and NPM1 Co-Mutations—A Single-Center Study from Turkey

    Current Issues in Molecular Biology, 2026

    DOI 10.3390/cimb48080752 PMID 42651751 Open-access full textSource: OpenAlex

  6. Outcomes of Brentuximab Vedotin Monotherapy in Refractory/Relapsed Classical Hodgkin’s Lymphoma: A Multi-Center Retrospective Study on Survival and Safety

    Indian Journal of Hematology and Blood Transfusion, 2025

    DOI 10.1007/s12288-025-02093-w PMID 42040698 1 citation (Europe PMC) Open-access full textSource: OpenAlex

  7. CalR and MPL Driver Mutations and Their Role in the Diagnosis and Clinical Course of JAK2-Unmutated Chronic Myeloproliferative Neoplasm: Results from a Pilot Single-Center Study

    Medicina, 2025

    DOI 10.3390/medicina61060962 PMID 40572650 Open-access full textSource: OpenAlex

  8. Congenital thrombotic thrombocytopenic purpura and human leukocyte antigen analysis–an amazing clue

    Hematology Transfusion and Cell Therapy, 2025

    DOI 10.1016/j.htct.2025.103746 PMID 39954327 Open-access full textSource: OpenAlex

  9. Impact of COVID-19 on Hematologic Disorders: Clinical Insights and Challenges

    Istanbul Medical Journal, 2025

    DOI 10.4274/imj.galenos.2024.17092 Source: OpenAlex

  10. Novel prognostic factor in thrombotic thrombocytopenic purpura: human leukocyte antigen class II

    Blood Coagulation & Fibrinolysis, 2025

    DOI 10.1097/mbc.0000000000001372 PMID 40772348 Source: OpenAlex

View all 176 publications